Anaphylaxis is a rapid, potentially fatal allergic reaction with a global prevalence of 0.04%‐1.8%. Early intramuscular epinephrine administration is recommended. However, fear, pain, cost, or social barriers often delay treatment, leading to poor outcomes. To address these challenges, an intranasal (IN) epinephrine fo...
Manav Jain, P. Yamamoto, Amira Soliman et al.· Journal of clinical pharmaco...· 0 citations
Findings support the integration of pharmacogenetic information into clinical decisionmaking to optimize ASM therapy and reduce the risk of drug resistance in epilepsy management.
Maria Madalena Corrêa Melo, J. P. V. Rodrigues, Luana Sueli Silva et al.· Brazilian Journal of Pharmac...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.